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Review
A General Propensity to Psychological Distress Affects
Cardiovascular Outcomes
Evidence From Research on the Type D (Distressed) Personality Profile
Johan Denollet, PhD; Angélique A. Schiffer, PhD; Viola Spek, PhD
Specific negative emotions have been related to adversecardiac events, but a general propensity to psychological
distress may also affect cardiovascular outcomes. In this
summary article, we provide a reliable estimate of the
prognostic risk associated with Type D (distressed) person-
ality, a general propensity to distress that is defined by high
scores on the “negative affectivity” and “social inhibition”
traits. Quantitative analyses of prospective studies that in-
cluded a total of 6121 patients with a cardiovascular condi-
tion indicated that Type D personality was associated with a
more than 3-fold increased risk of adverse events (9 studies)
and long-term psychological distress (11 studies). In addition,
a narrative review of 29 studies showed that Type D person-
ality and depression are distinct manifestations of psycholog-
ical distress, with different and independent cardiovascular
effects. There are also plausible biological and behavioral
pathways that may explain this adverse effect of Type D
personality. The findings reported in this summary article
support the simultaneous use of specific and general mea-
sures of distress in cardiovascular research and practice.
General Propensity to Distress
Depression, anxiety, anger, and posttraumatic stress are
specific markers of distress that have been related to cardiac
disorder,1–5 whereas broader markers of psychological dis-
tress have received substantially less attention in cardiovas-
cular research.6 However, the general distress shared across
these specific markers may predict the development of
coronary heart disease1 and may also partly account for the
association of depression and anxiety with myocardial infarc-
tion,3 poor cardiac prognosis,4 and autonomic cardiac dys-
regulation.7 Hence, the conceptual idea of psychological
distress as a cardiovascular risk marker may be broadened to
include a general propensity to distress.
Many studies report on depression, anxiety, and cardiovas-
cular outcomes.2–4 Although patients may go in and out of
depressive and anxious episodes, there is an underlying trait
factor that predisposes patients to chronic distress.8 Symp-
toms of depression/anxiety not only reflects episodic distress
but also a more ingrained tendency to experience distress,3,9
with the combination of distress and social isolation predict-
ing poor cardiac prognosis.10,11 Accounting for this general
propensity to psychological distress offers the opportunity to
flag high-risk patients that may benefit from a more person-
alized approach to cardiac care. The “distressed” or Type D
personality12–15 refers to a chronic, more covert form of
distress that is distinct from depression. Type D patients are
inclined to experience negative emotions (negative affectiv-
ity) and to inhibit self-expression in social interaction (social
inhibition).15 Several studies from our research group have
examined the notion that Type D personality is a general
propensity to psychological distress that affects cardiovascu-
lar outcomes.16,17 The determinants of psychological distress
as a cardiac risk marker1–5 are still unclear; hence, a number
of these studies also focused on the role of Type D as
predictor of distress.
In identifying chronically distressed patients, we can de-
velop new interventions to minimize the adverse conse-
quences of negative emotions on cardiovascular outcomes.
To have added value, this general propensity to distress
should show a substantial effect on cardiovascular outcomes
and should show this effect, irrespective of measures of
depression. The purpose of this paper was to summarize the
findings from our follow-up research on Type D personality
that were published over a 15-year period (between 1995 and
2009). This summary includes both a quantitative synthesis
and a narrative review that address 2 issues: (1) What is the
increase in prognostic risk associated with Type D personal-




To provide a reliable estimate of the prognostic risk associated with
Type D personality, we performed a quantitative analysis of aggregate
findings from our Type D studies that were published between 1995 and
2009. Two of the authors (V.S. and A.S.) and a librarian also searched
for Type D studies from other research groups through systematic
literature searches in the databases of PubMed and PsychINFO (1995 to
2009). Searches were conducted using the following search terms:
“Type D (type-D, Type-D)” AND “cardiovascular disease/cardiac
From the CoRPS–Center of Research on Psychology in Somatic diseases (J.D., A.A.S., V.S.), Tilburg University, Tilburg, The Netherlands; and the
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disease/coronary heart disease/myocardial infarction”; “Type D (type-
D/Type-D)” AND “cardiovascular disease/cardiac disease/coronary
heart disease/myocardial infarction” AND “depression/depressive
symptoms.” We also checked reference lists of retrieved studies and of
2 earlier narrative reviews on Type D.16,17
The following criteria were used to select prognostic studies on
Type D personality: (1) the study focuses on Type D personality in
relation to hard medical outcomes (ie, death or recurrent MI) or
emotional distress (ie, depression, anxiety and poor mental health
status); (2) the study uses a prospective design; (3) the study was
conducted in a cardiovascular population; (4) the study reports
multivariable odds ratios that adjust for disease severity; and (5)
when there was an overlap between samples across studies, only 1 of
these studies was included. The retrieved studies were independently
assessed (by A.S. and V.S.) on the above-mentioned inclusion
criteria. The degree of agreement on the selection of prognostic
studies was high; there was only disagreement on studies of patients
with peripheral arterial disease, but, eventually, these studies were
included in the analyses. The systematic literature searches did not
yield prognostic Type D studies from other research groups, and we
are not aware of any unpublished negative studies by others.
Quantitative Synthesis of Aggregate Findings
Meta-analytic reports usually combine studies from diverse sources
of research groups; hence, the current quantitative analysis that
aggregated findings from our own research group should not be
regarded as a meta-analysis in a standard way. However, given the
fact that there is some disparity in data from our published reports,
as indicated by a wide range in odds ratios and confidence intervals
of the individual reports, the purpose of this summary article was to
reliably estimate the risk associated with Type D personality in our
research on cardiovascular patients and to enhance interpretation of
published reports.
The fact that all studies included in the quantitative synthesis
originated from our own group clearly precludes an independent
rating of the quality of the studies; hence, we did not check the
quality of reporting of our own research. However, the second and
last author (A.S. was involved in 3 studies; V.S. was not involved in
any study) used the 14-item rating of the “Methods and Results” part
of the STROBE criteria18,19 to provide an indication of the method-
ological quality of the studies. The mean score for methodological
quality was 12.9 (of 14); the most common methodological problem
was the absence of an a priori power calculation. Regarding the
quality of the individual reports, it should be noted that the
prognostic studies were published in well respected journals and that
all papers have been scrutinized by scrupulous and dedicated
reviewers before being accepted for publication.
The computer program Comprehensive Meta-analysis, version
2.2.021 (Biostat, Englewood, NJ) was used to calculate pooled mean
odds ratios. Because we did not know whether we could expect
heterogeneity across studies, both fixed- and random-effects models
were used to calculate the pooled effect size. Heterogeneity was
calculated with the Q-statistic and the I2-statistic. A significant Q
indicates that the variability among the effect sizes is greater than
what is likely to have resulted from subject-level sampling error
alone.20 I2 describes the percentage of total variation across studies
that is due to heterogeneity rather than chance. I2-values of 25%,
50%, and 75% are associated with low, moderate, and high hetero-
geneity.21 Post hoc subgroup analyses included both fixed-effects
and mixed-effects analyses. In fixed-effects analyses, the model
calculates the fixed-effect sizes for each subgroup of studies-, and for
the difference between subgroups. In mixed-effects analyses, the
random-effects model calculates the effect size for each subgroup,
whereas the fixed-effects model examines the difference between
subgroups of studies. Separate analyses were conducted for progno-
sis and distress. Publication bias was estimated visually by funnel
plots and by calculating the fail-safe N, the number of nonsignificant
studies that would be necessary to reduce the effect size to a
nonsignificant value.
Narrative Review of Type D and Depression
The narrative part of this summary article focused on studies that
included the assessment of both Type D personality and symptoms/
diagnosis of depression. To have added value, the general propensity to
psychological distress as defined by the Type D construct should affect
cardiovascular disorder, irrespective of established measures of
depression.
In addition to studies that reported on (1) conceptual differences
between Type D personality and depression; this part of the article also
included studies that reported on (2) the independent prognostic power
of Type D personality after adjustment for depression, (3) the relation of
Type D personality and depression to biological mechanisms of disease,
and (4) the role of Type D personality and depression in patient-reported
health outcomes. Assessment of depression in these studies was based
on standard interview ratings of the diagnosis and severity of depression
or validated self-report scales of depressive symptoms. This narrative
review of studies that assessed both Type D personality and depression
included 23 reports from our own research group and 6 reports from
other research groups.
Results
Nineteen studies with 6121 patients were included in quan-
titative data synthesis of Type D follow-up studies on
prognosis (Table 1) and psychological distress (Table 2);
there was no overlap in patient samples. There was 1 study
that reported on both prognosis and psychological distress.23
All studies were published between 1996 and 2009.
Type D Personality and Prognosis
Nine prospective Type D studies reported on long-term progno-
sis, including (cardiac) death, myocardial infarction, and revas-
cularization (Table 1). Six reports on prognosis were published
in cardiology journals (Circulation,23,27 J Am Coll Cardiol,25
Am J Cardiol,24 Eur J Cardiovasc Prev Rehabil,26 and Int
J Cardiol28) and 3 in other biomedical journals (Lancet,22
J Heart Lung Transplant,29 and Arch Surg30). In patients with
coronary heart disease, Type D personality was associated with
an odds ratio 2.5 in 2 studies24,26 and an odds ratio 3.8 in 4
studies.22,23,25,27 Type D personality was also associated with an
odds ratio 2.3 in heart failure,28 heart transplantation,29 and
peripheral arterial disease.30
There was no significant heterogeneity among these stud-
ies on prognosis, (Q6.6, df8, P0.001, I20.0%), indi-
cating that the pooling of studies was warranted.
Examination of the pooled effect size indicated that Type
D personality was associated with a more than 3-fold in-
creased risk of poor long-term prognosis (Figure 1). The
mean odds ratio of all 9 prospective studies on prognosis was
3.7 (95% confidence interval, 2.75.1) in both the fixed-
effects and random-effects models (Table 3, top). Publication
bias was estimated visually by funnel plots, and the fail-safe
N was 151 for studies on cardiac prognosis.
Type D Personality and Emotional Distress
Eleven papers reported on the prediction of emotional distress
(anxiety, depression, vital exhaustion, and poor mental
health); these studies were published in cardiology,23,33,34,38
surgery,39,40 and psychiatry31,32,35–37 journals (Table 2). In
coronary patients, Type D was associated with an odds ratio
1.9 in 3 studies23,34,36 and 3.0 in 4 studies.31–33,35 The odds
ratio was 3.8 in heart failure37,38 and peripheral arterial
disease39,40 patients.
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The fixed-effects (odds ratio3.2) and random-effects
(odds ratio3.4) models yielded slightly different results
(Figure 2). There was significant heterogeneity (Table 3;
Q13.76). Therefore, post hoc analyses were performed for
cardiac and peripheral arterial disease subgroups. In cardiac
patients, the mean odds ratio was 2.9 for both models, and
heterogeneity was much lower than in the total sample (Table
3; subgroups distress). In the subgroup of patients with
peripheral arterial disease, the mean odds ratio was 7.0 for
both models, and there was no significant heterogeneity
(Table 3; subgroups distress). Publication bias was estimated
visually by funnel plots and by calculating the fail-safe N,
which was 346 for studies on emotional distress.
Studies Excluded From Quantitative Analysis
Three publications on Type D personality and prognosis that
were published between 1995 and 2008 (Psychosom Med,14
Eur Heart J,41 and Arch Intern Med42) were excluded from
quantitative analysis because of overlap with samples of 3
other published papers.22,24,25 One study showed that the
combination of social inhibition and negative affectivity
(rather than the isolated effect of 1 of these traits) was
associated with adverse events after coronary stenting41 and
another that Type D personality was independently associated
with adverse events in coronary patients, after adjustment for
depressive symptoms.42
Narrative Review of Type D Personality
and Depression
Twenty-nine studies reported on both Type D personality and
depression in cardiovascular patients (Table 4). Eleven studies
were published in cardiology journals,23,27,33,38,41,47,52,56–59
2 in general medicine,22,42 and 16 in psychiatry/
psychology.35–37,43– 46,48 –51,53–55,60,61
The Composite International Diagnostic Interview (CIDI)43,50
or Hamilton Depression rating scale49 was used in 3 studies to
assess clinical depression. Most studies used the Beck Depres-
sion Inventory (BDI),37,38, 42,44,45,48,52–58,61 Hospital Anxiety and




CVD N Type D (n) FU Prognosis OR* Covariates
Denollet22 (1996) Lancet CAD 303 28% (85) 6–10
years
Cardiac death OR3.8 LVEF, multivessel disease, poor
exercise tolerance, lack of
thrombolytic therapy
Denollet23 (2000) Circulation CAD 319 31% (99) 5 years Cardiac death and MI OR8.9 LVEF
Age
Denollet24 (2006) Am J Cardiol CAD 337 29% (98) 5 years MACE OR2.9 LVEF, index MI, no CABG at
baseline
Age, sex, psychological stress
Pedersen25 (2004) J Am Coll Cardiol CAD 875 29% (254) ¾ year Death and MI OR5.3 Previous CABG, bare vs
drug-eluting stent
Age, sex
Pedersen26 (2007) Eur J Cardiovasc Prev
Rehabil





Denollet27 (1998) Circulation MI 87 31% (27) 6–10
years
Cardiac death and MI OR4.8 LVEF, multivessel disease, poor
excercise tolerance, history of
previous MI
Smoking, depression, anxiety, anger
Schiffer28 (2010) Int J Cardiol CHF 232 21% (48) 2.6 years Cardiac death OR2.3 LVEF
Age, sex
Denollet29 (2007) J Heart Lung
Transplant
HTx 51 29% (15) 5.4 years Death, severe/early allograft
rejection




HLA, CMV), allograft type,
urgent transplantation
Age, sex




*All odds ratios are multivariably adjusted; covariates are stated in the column on the far right.
BMI indicates body mass index; CABG, coronary artery bypass graft surgery; CAD, coronary artery disease; CHF, chronic heart failure; CMV, cytomegalovirus; CVD,
cardiovascular disease; FU, follow-up; HTx, heart transplantation; LVEF, left ventricular ejection fraction; MACE, major adverse cardiac event; MI, myocardial infarction;
OR, odds ratio; and PAD, peripheral arterial disease.
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CVD N Type D (n) FU Emotional Distress OR* Covariates
Denollet23 (2000) Circulation CAD 319 31% (99) 5 years Depressive affect
(GMS, NA/PA)
OR2.6 Sex, smoking, depression, anxiety
Pedersen31 (2001) J Psychosom
Res
CAD 171 29% (49) 6 weeks Vital exhaustion
(MQ 14)
OR4.7 NHYA class, cardiac treatment
Age, sex, education, marital status,
work status
Pedersen32 (2007) J Psychosom
Res
CAD 419 25% (104) 1 year Vital exhaustion
(MQ 14)
OR3.5 Multivessel disease, unstable angina,
drug-eluting stent, cardiac history,
hypertension, dyslipidemia, diabetes
Age, sex, smoking, baseline
exhaustion
Pedersen33 (2006) Am Heart J CAD 542 17% (94) ½ year Depressive symptoms
(HADS-D 8)





CAD 692 27% (190) 1 year Poor mental health
(SF-36 low tertile)




Age, sex, SES, smoking, baseline
health status
Spindler35 (2007) J Affect
Disorders
CAD 167 59% (98) ½ year Anxiety symptoms
(HADS-A 8)
OR3.3 Multivessel disease, drug-eluting
stent, cardiac history, hypertension,
dyslipidemia, diabetes, renal
impairment
Age, sex, smoking, depression
van Gestel36 (2007) J Affect
Disorders
CAD 416 25% (103) 1 year Anxiety symptoms
(HADS-A 8)
OR2.9 Multivessel disease, unstable angina,
cardiac history, recent event,
hypertension, dyslipidemia, diabetes
Age, sex, living alone, smoking,
depression, baseline anxiety
Schiffer37 (2008) J Affect
Disorders
CHF 149 23% (35) 1 year Anxiety mild/severe
(HAM-A 17)
OR5.3 LVEF, NYHA class, ischemia,
hypertension
Age, sex, education, partner status,
smoking, depression, anxiety
sensitivity
Schiffer38 (2008) Eur J Heart
Failure
CHF 166 23% (38) 1 year Poor mental health
(SF-36, low tertile)




Age, sex, education, baseline mental
health status
Aquarius39 (2007) J Vasc
Surg
PAD 203 34% (69) 1 year Poor mental health
(RAND, low quartile)
OR6.0 Ankle-brachial index, claudication
distance
Age, sex
Aquarius40 (2007) Arch Surg PAD 150 35% (52) ½ year Depressive symptoms
(10-item CES-D 4)
OR8.6 Ankle-brachial index, walking
distance (pain free, maximum),




*All odds ratios are multivariably adjusted; covariates are stated in the column on the far right.
ACE indicates angiotensin-converting enzyme; CAD, coronary artery disease; CES-D, Center for Epidemiological Studies Depression Scale (10-item Boston form);
CHF, chronic heart failure; CVD, cardiovascular disease; FU, follow-up; GMS, Global Mood Scale (NA/PA: high negative affect paired with low positive affect as
defined by median split); HADS, Hospital Anxiety and Depression Scale; HAM-A, Hamilton Anxiety Rating Scale; LVEF, left ventricular ejection fraction; MQ, Maastricht
Questionnaire; NYHA, New York Heart Association; OR, odds ratio; PAD, peripheral arterial disease; RAND, RAND-36 mental health domains; SES, socioeconomic
status; and SF-36, Short-Form Health Survey-36.
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Depression Scale (HADS),33,35,36,41,44,46,51,59,60 or other self-
report measures22,23,27,47 of depressive symptoms. This review
included 8 studies that reported on conceptual differences,33,42–48
6 studies on the prediction of adverse events,22,23,27,41,42,49 6
studies on biological mechanisms of disease,50–55 and 10 studies
on perceived health status and anxiety.35–38,56–61
Overlap Between Type D personality
and Depression
From a conceptual point of view, evidence indicates that
Type D personality and depression are only partly overlap-
ping. Most Type D patients do not cross the diagnostic
threshold for clinical depression,43 and similar findings were
found regarding self-reported depression.42 Factor analysis
including the BDI and HADS depression scales confirmed
that the items from the 14-item Type D Scale (DS14)15 were
distinctly different from depressive symptoms in cardiac
patients.44 In addition, Type D predicted the onset of depres-
sive symptoms in patients who were free from depression at
baseline33 and predicted the prevalence46,47 and persistence48
of depressive symptoms, adjusting for baseline levels of
depression.
Differences Between Type D Personality
and Depression
In 5 follow-up studies of cardiac patients, Type D personality
independently predicted adverse cardiac events, adjusting for
symptoms22,23,27,42 and severity49 of depression. In another study,
Type D personality but not depressive symptoms predicted
adverse events.41 Although left ventricular dysfunction has been
related to an increased risk of depression,50 it is less likely that
Type D is confounded by the severity of cardiac disorder.
Clinical markers of disease severity are not related to Type D
personality,45,50 and the association between Type D and cardio-
vascular outcomes remains after adjustment for disease severity
(see Table 1). One study reported that depression but not Type
D was associated with atrial fibrillation,51 whereas another study
showed that anxious Type D patients were at risk of ventricular
arrhythmia and that depressive symptoms were unrelated to
arrhythmia.52 Three studies in cardiac patients showed that Type
Figure 1. Meta-analysis of Type D personality and prognosis. Note: All odds ratios were multivariably adjusted (see Table 1). EJCPR
indicates Eur J Cardiovasc Prev Rehabil; JACC, J Am Coll Cardiol; and JHLT, J Heart Lung Transplant.
Table 3. Meta-Analyses of Type D Studies on Prognosis and Emotional Distress
Nstudies OR 95% CI Q P I
2 (%)
Total group
Prognosis 9 FEM 3.7 2.75.1 6.6 0.01 0.0
REM 3.7 2.75.1
Emotional distress 11 FEM 3.2 2.63.9 13.76 0.18 27.4
REM 3.4 2.64.3
Subgroup distress
Cardiac disease 9 FEA 2.9 2.33.6 7.74 0.46 0.0
MEA 2.9 2.33.6
Peripheral arterial disease 2 FEA 7.0 3.513.8 0.25 0.62 0.0
MEA 7.0 3.513.8
OR indicates odds ratio; CI, confidence interval; FEM, fixed-effects model; REM, random-effects model; FEA,
subgroup analysis based on the fixed-effects model; and MEA, subgroup analysis based on the mixed-effects model.
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D remained significantly related to increased levels of corti-
sol53,54 and oxidative stress,55 after adjustment for depressive
symptoms.
In a study of coronary patients, depressive symptoms but
not Type D predicted return to work.56 In another study, Type
D personality but not depression was associated with poor
health status 1 year after coronary bypass surgery.59 After
control for depressive symptoms, Type D personality was
also associated with poor health status and fatigue in myo-
cardial infarction57 and heart failure38,58 patients and in
patients who participated in cardiac rehabilitation.60 In a
study of patients with an acute coronary syndrome, Type D
predicted posttraumatic stress symptoms but adjustment for
depressive symptoms attenuated this relationship.61 Finally,
Type D personality predicted the prevalence,36 persistence,35
and severity37 of anxiety symptoms in cardiac patients,
adjusting for depressive symptoms.
Discussion
Risk Associated With Type D
Individual published reports on Type D personality have yielded
some disparity in data as indicated by a wide range in odds ratios
and confidence intervals across studies. This summary article
provides a more reliable estimate of the increase in risk associ-
ated with Type D personality. Quantitative analysis of prospec-
tive studies from our group indicated that Type D personality
was associated with a more than 3-fold increased risk of poor
prognosis, with the 95% confidence interval of this pooled odds
ratio ranging from 2.7 to 5.1.
Only multivariable odds ratios that adjusted for demo-
graphic and clinical variables were used in quantitative data
analysis. Type D personality was also associated with a 3-fold
(range, 2.6 to 4.3) increased risk of distress, which enhanced
the generalizability of findings. These studies found that Type
D personality independently predicted anxiety36,37, poor men-
tal health,34,38 and vital exhaustion32 after adjustment for
baseline levels of distress. Overall, these findings suggest that
general distress affects cardiovascular outcomes.
Type D Is Not Depression
Depression is an episodic risk marker and Type D a chronic
risk marker for clinical manifestations of coronary disease.8
Although depression reflects a psychiatric disorder, Type D
refers to normal personality traits, with most Type D patients
not meeting diagnostic criteria for depression.43 Some Type D
individuals will only cross the threshold for affective disorder
during times of elevated stress, and still others will display
subclinical levels of distress all their lives.62 Type D and
depression are only partly overlapping,42,43 and factor ana-
lytic research showed that items from the Type D personality
scale are different from depressive symptoms.44,63
After adjustment for co-occurring depression symptoms,
Type D personality remains independently associated with an
increased risk of clinical events.22,23,27,41,42,49 This suggests
that both constructs involve distinct pathways of disease.
Evidence also shows that after control for depressive symp-
toms, Type D was associated with ventricular arrhythmia,52
increased cortisol,53,54 and oxidative stress55 in cardiac pa-
tients. Further, Type D predicted the onset,33 preva-
lence,36,46,47 persistence,35,48 and severity37 of depression and
anxiety symptoms in cardiac patients, adjusting for baseline
depression scores. In addition, Type D is associated with poor
health status and fatigue,38,57–60 adjusting for depressive
symptoms.
These findings do not imply that Type D is better than
depression in the prediction of cardiac outcomes; they simply
indicate that general distress may have incremental value.
Rather than antonymous perspectives, specific (depression,
anxiety) and general (Type D) approaches to distress repre-
sent complementary perspectives that have additional value
Figure 2. Meta-analysis of Type D personality and emotional distress. Note: All odds ratios were multivariably adjusted (see Table 2).
JAD indicates J Affect Disorders; and JPR, J Psychosom Res.
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Table 4. Studies That Included Both Type D Personality and Depression Assessment






Affective disorder CIDI 224 patients were Type D and 206 had depression;





Depression symptoms BDI 43 patients were Type D only and 58 had depression







Type D personality traits were distinctly different





Depression symptoms BDI Type D classification was not confounded by





Depression symptoms HADS Type D predicted onset of depressive symptoms in
patients who were free from depression at baseline
Spindler46 (2009)
Int J Behav Med
CAD/CHF
n318
Depression symptoms HADS Type D independently predicted depression,





Depression symptoms MQ-D Type D independently predicted depression,





Depression symptoms BDI Type D independently predicted persistence of






Depression severity HAM-D Type D independently predicted cardiac death/MI,





Depression symptoms BDI Type D independently predicted major adverse





Depression symptoms HADS Type D independently predicted major adverse cardiac







MBHI Type D independently predicted cardiac death;







MBHI Type D independently predicted cardiac death/MI;





Despondency HPPQ Type D independently predicted cardiac death/MI;






Affective disorder CIDI Type D was not associated with disease severity;





Depression symptoms HADS Type D was not associated with atrial fibrillation;
depression independently predicted atrial fibrillation
van den Broek52 (2009)
J Am Coll Card
ICD
n391
Depression symptoms BDI Anxious Type D patients were at risk of ventricular





Depression symptoms BDI Type D was associated with an increased cortisol





Depression symptoms BDI Type D independently predicted increased cortisol





Depression symptoms BDI Type D was associated with oxidative stress levels;
depression was not related to oxidative stress





Depression symptoms BDI Type D not related to returning to work; depression
independently predicted failure to resume work
Schiffer38 (2008)
Eur J Heart Fail
CHF
n166






Depression symptoms BDI Type D was associated with poor health status and
unstable angina, adjusting for depression
Smith58 (2007)
Eur J Heart Fail
CHF
n136
Depression symptoms BDI Type D independently predicted symptoms of





Depression symptoms HADS Type D independently predicted poor health status;





Depression symptoms HADS Type D independently predicted poor health status before
and after rehabilitation, adjusting for depression
(Continued)
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in outcomes research. Research from our group is not limited
to Type D but also focuses on anxiety,2 depression,64 and
anhedonia.65 Hence, we propose to capitalize on the simulta-
neous use of specific and general measures of distress in
cardiac research and practice. This review provides both
empirical and conceptual reasons to further explore Type D
as a general propensity to psychological distress that affects
cardiovascular outcomes.
Limitations of the Type D Construct
The fact that all prognostic studies included in the quantita-
tive analysis reported on findings from our research group
precluded an independent rating of the quality of studies.
Hence, replication in other cultures and by other research
groups is needed. Recent publications from independent
research groups are promising and support the role of Type D
as a determinant of genetic,66 biological,53,54,67–72 and behav-
ioral73–79 pathways of disease that promote a better under-
standing of the effect of psychological distress on cardiac
disorder.
There are also mixed findings on Type D personality. In a
study of coronary patients, adjustment for depression attenu-
ated the relation between Type D and posttraumatic stress.61
Recently, we found that neither Type D personality nor
anxiety/depression symptoms were related to cardiac mortal-
ity in heart failure patients,80 but the power of this study was
low. Other very recent studies from our group showed that
Type D independently predicted an increased risk of mortal-
ity after myocardial infarction49 or implantable cardioverter-
defibrillator treatment (S.S. Pedersen, PhD; unpublished data,
2010) and that Type D accounted for the observed association
between suppressed anger and adverse events.81 Although
one study found that depression and not Type D was related
to atrial fibrillation,51 another reported that Type D predicted
poor outcome of atrial fibrillation.82 In patients with pulmo-
nary disease, depressive symptoms and not Type D predicted
mortality,83 whereas other research groups showed that Type
D was associated with impaired health status in patients with
sleep apnea,75 mild brain injury,76 Parkinson disease,84 gas-
trointestinal disorders,85 or medical comorbidities78 and in
individuals from the general population.86 Our group showed
that Type D was related to poor health status in melanoma
survivors.87
In the literature, there is an ongoing discussion whether
Type D is more accurately represented as a dimensional
rather than categorical construct.88 Dimensional and categor-
ical approaches to personality are not mutually exclusive but
represent 2 ways of capturing psychological tendencies of
individuals.78 Type D refers to individuals who are more
similar to their subgroup’s personality profile than other
personality profiles,62 but, of course, individuals belong only
probabilistically to these subgroups. However, similar pat-
terns of standing along the negative affectivity and social
inhibition traits do occur across patients, constituting reliable
configurations summarized by Type D.78
Incremental Value of the Type D Construct
Despite its limitations, the Type D construct has much explan-
atory and predictive power. The Type D construct was derived
from personality theory,22 and recent data support its genetic
underpinnings66 and heritability.89 The Type D classification in
cardiac patients is not confounded by temporary changes in
mood status15 or depressive symptoms45 and is stable over
time.45 Neuroimaging research also shows that Type D is related
to emotion processing in the brain, as indicated by a decreased
differential activity in the amygdale.90
Type D personality is characterized by high neuroticism,
low extraversion, and low conscientiousness, but these traits
and Type D share less than 50% variance15 and thus are not
interchangeable. Head-to-head comparisons of neuroticism,
extraversion, and Type D indicated that Type D had unique
empirical value in patients with brain injury76 or medical
comorbidities78 and that Type D independently predicted
posttraumatic stress91 and adverse events92 in cardiac pa-
tients. Type D is also related to increased stress reactivity68
and poor health behavior,73 adjusting for hostility or neurot-
icism. Type D is distinct from repressive coping, with both
traits independently predicting cardiac events.93 Hence, au-
thors from other groups have noted that Type D is a new
personality construct that contributes to our understanding of
the cardiovascular effects of stress68 and that Type D “em-
bodies unique information relevant to health that is not
captured by multiple trait ratings.”78
Table 4. Continued






Depression symptoms HADS Type D independently predicted persistence of





Depression symptoms HADS Type D independently predicted increased anxiety





Depression symptoms BDI Type D independently predicted clinically significant





Depression symptoms BDI Type D related to posttraumatic symptoms; after
adjustment for depression, no longer significant
ACS indicates acute coronary syndromes; BDI, Beck Depression Inventory; CAD, coronary artery disease; CHF, chronic heart failure; CIDI, Composite International
Diagnostic Interview; EJCPR, European Journal of Cardiovascular Prevention and Rehabilitation; HADS, Hospital Anxiety and Depression Scale; HAM-D, Hamilton
Depression rating scale; HPPQ, Heart Patients Psychological Questionnaire; ICD, implantable cardioverter-defibrillator; IHD, ischemic heart disease; MBHI, Millon
Behavioral Health Inventory; MQ-D, depression subscale of the Maastricht Questionnaire; and MI, myocardial infarction.
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Biological and Behavioral Pathways
Although the diagnosis of cardiac disease may perhaps affect
self-ratings of personality,13 it is less likely that Type D is a
response to disease. Unlike the association between left
ventricular dysfunction and depression,50 Type D is not
confounded by severity of cardiac disorder45,50 or heart
failure.94 The Type D scale does not include somatic symp-
toms, and Type D predicts adverse events, adjusting for
disease severity and other clinical risk factors.
There are plausible pathways that may explain the increase
in risk in Type D patients. In experimental research, Type D
has been related to higher cardiovascular stress reactivity,
including increased heart rate, blood pressure and cardiac
output,67,68 and decreased heart rate variability.69 In cardiac
patients, Type D personality has been associated with reduced
heart rate recovery70 and with the incidence of ventricular
arrhythmia.52 A dysfunctional hypothalamic-pituitary-adrenal
axis comprises another potential pathway.71 Type D is related
to greater cortisol reactivity to stress68 and to increased
awakening53 and daytime54 cortisol levels in coronary pa-
tients. In heart failure patients, Type D personality is associ-
ated with increased activity of proinflammatory cytokines95
and a dysfunctional cytokine network.96 Other heart failure
studies found that Type D was independently associated with
increased oxidative stress55 and that bone marrow–derived
progenitor cells numbers were reduced by more than 50% in
Type D as compared with non–Type D patients.97
Behavioral mechanisms include an unhealthy lifestyle,73
low adherence to medical treatment,74,75 and reluctance to
consult clinical staff.98 In general, Type D individuals are less
likely to get a regular medical checkup.73 The inhibited
interpersonal style of Type D patients may impede effective
communication with their attending physician. Heart failure
patients with a Type D personality experience more cardiac
symptoms than non–Type Ds but, paradoxically, may be less
likely to consult for these symptoms.98 Type D also predicts
poor medication adherence after myocardial infarction,74 and
Type D individuals are less likely to adhere to continuous
positive airway pressure treatment of obstructive sleep ap-
nea.75 Finally, Type D individuals are vulnerable to stress24
and have a limited ability to bounce back from stressful
events.77 In the face of stress, they use more passive coping
strategies (eg, disengagement)79 and are not likely to seek
appropriate mental care.73
Toward More Individualized Cardiac Care
The relationship between mind and heart is complex.99
Because health care providers are trained to “find patterns”
and think categorically,78 the delineation of Type D may help
them to identify high-risk patients.62 A broader conceptual-
ization of psychological distress as a cardiovascular risk
marker has often wrongly been considered as being too
vague.6 Broad immunomodulation therapy that focuses on
cytokine networks is more successful in improving cardiac
survival as compared with therapies that target specific,
single cytokines.100 In analogy, it is possible that a broad
approach to behavioral intervention that targets the network
of emotional and social problems might also enhance survival
in cardiac patients101 and that Type D patients in particular
may benefit from such an approach. Cardiac patients are not
“doomed” because they have a Type D personality; in fact,
Type D patients may learn new strategies to reduce their level
of distress and to improve their social skills.102 Type D
personality has now been included in 2 ongoing randomized,
controlled behavioral intervention trials in Italian103 and
German104 cardiac patients, and new studies from our own
group will also examine whether the risk associated with
Type D can be modified.
Psychological distress as a prognostic risk marker does not
fall into the “one size fits all” category but includes many
different facets.99 The summary of findings in this article
suggests that Type D may be such a factor. People differ
substantially in their level of vulnerability to psychological
distress and the assessment of Type D may flag patients that
have a more than 3-fold increased odds of poor prognosis or
other adverse health outcomes. Of course, the reliability of
this estimated risk only applies to those specific populations
that were included in our studies. Hence, it is not possible to
generalize the results of the current quantitative analyses to
other cardiovascular populations without further independent
studies. One should also keep in mind that Type D research
does not assert any causal claim regarding the incidence of
cardiovascular disease but is merely focused on the associa-
tion between general distress and prognosis in cardiovascular
populations.
Assessment of Type D personality may also increase our
understanding of substantial interpatient variability in the
outcome of invasive treatments such as coronary bypass
surgery,59 coronary stenting,25 implantation of cardioverter-
defibrillators,52 or heart transplantation29 that cannot be ex-
plained by clinical risk factors. Outcomes research focuses on
patient-centered health outcomes such as health status,105 but
there is a gap in our understanding of the determinants of
these outcomes.106 Previous research has focused on age107
and sex108 differences in cardiovascular outcomes. Findings
from Type D research indicate that individual differences in
general distress should also be accounted for when quantify-
ing these outcomes.31–40,57–60 In addition, Type D has been
related to poor health in conditions such as sleep apnea,75
brain injury,76 or cancer.87 Finally, Type D has been associ-
ated with an increased risk of suicidal ideation, adjusting for
depressive symptoms.109
This summary article is largely limited to reports from our
own group. Type D personality is a new construct, and there
is a need for prospective studies from independent research-
ers. Lately, the number of Type D studies from other research
groups has increased rapidly. Although some have reported
negative findings,51,56,83 most of these studies support the role
of Type D personality as a determinant of mechanisms of
disease53,54,66 –79 and impaired health status in clini-
cal59,61,75,76,78,82,84,85 and nonclinical73,74,77,79,86 populations.
This summary indicates that in addition to depression, a
general propensity to distress, as defined by standing on
negative affectivity and social inhibition in the Type D
model, affects cardiovascular outcomes. Type D only partly
overlaps with depression and provides additional health-
relevant information that is not captured by other trait
ratings.78 Currently, individual differences in the general
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propensity to psychological distress are largely ignored in
outcomes research. With the introduction of the 14-item Type
D Scale (DS14) as a brief measurement tool,15 this “individ-
ual difference” assessment of general distress can be easily
accomplished with little patient burden and may enhance
individualized cardiac care.110
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